The University of Osaka University’s Department of Cardiovascular Surgery seek government approval by the end of October to commence a clinical trial using iPS cells to treat a serious heart condition. The team will be led by Yoshiki Sawa, professor at Osaka...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
